Pan C - Search Results

Year	Number of Results
1950	2
1951	3
1952	3
1953	3
1954	3
1955	1
1956	2
1957	3
1958	7
1959	1
1960	3
1961	5
1962	1
1963	5
1964	2
1965	4
1966	2
1968	1
1969	1
1970	1
1971	3
1977	1
1978	2
1979	1
1980	4
1981	5
1982	5
1983	3
1984	9
1985	10
1986	10
1987	11
1988	23
1989	8
1990	13
1991	19
1992	22
1993	16
1994	15
1995	16
1996	24
1997	16
1998	27
1999	30
2000	30
2001	31
2002	48
2003	69
2004	104
2005	117
2006	126
2007	143
2008	161
2009	171
2010	232
2011	272
2012	316
2013	345
2014	342
2015	393
2016	419
2017	466
2018	491
2019	561
2020	658
2021	821
2022	865
2023	896
2024	811
2025	5

1

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.

Li G, Wang D, Zhai Y, Pan C, Zhang J, Wang C, Huang R, Yu M, Li Y, Liu X, Liu Y, Wu F, Zhao Z, Hu H, Shi Z, Kahlert UD, Jiang T, Zhang W. Li G, et al. Among authors: pan c. Cell Metab. 2024 Aug 6;36(8):1696-1710.e10. doi: 10.1016/j.cmet.2024.07.011. Cell Metab. 2024. PMID: 39111285 Free article.

2

Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis.

Guo P, Wang W, Xiang Q, Pan C, Qiu Y, Li T, Wang D, Ouyang J, Jia R, Shi M, Wang Y, Li J, Zou J, Zhong Y, Zhao J, Zheng D, Cui Y, Ma G, Wei W. Guo P, et al. Among authors: pan c. Cell Host Microbe. 2024 Sep 11;32(9):1502-1518.e9. doi: 10.1016/j.chom.2024.07.028. Epub 2024 Aug 27. Cell Host Microbe. 2024. PMID: 39197456

3

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. ADVANCE Collaborative Group, et al. Among authors: pan c. N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539916 Free article. Clinical Trial.

4

Small-molecule agents for cancer immunotherapy.

Wang F, Fu K, Wang Y, Pan C, Wang X, Liu Z, Yang C, Zheng Y, Li X, Lu Y, To KKW, Xia C, Zhang J, Shi Z, Hu Z, Huang M, Fu L. Wang F, et al. Among authors: pan c. Acta Pharm Sin B. 2024 Mar;14(3):905-952. doi: 10.1016/j.apsb.2023.12.010. Epub 2023 Dec 16. Acta Pharm Sin B. 2024. PMID: 38486980 Free PMC article. Review.

5

Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment.

Wu Q, Pan C, Zhou Y, Wang S, Xie L, Zhou W, Ding L, Chen T, Qian J, Su R, Gao X, Mei Z, Qiao Y, Yin S, Wu Y, Wang J, Zhou L, Zheng S. Wu Q, et al. Among authors: pan c. Hepatology. 2023 Nov 1;78(5):1402-1417. doi: 10.1097/HEP.0000000000000320. Epub 2023 Feb 23. Hepatology. 2023. PMID: 36811396

6

Peripheral peroxisomal β-oxidation engages neuronal serotonin signaling to drive stress-induced aversive memory in C. elegans.

Tsai SH, Wu YC, Palomino DF, Schroeder FC, Pan CL. Tsai SH, et al. Among authors: pan cl. Cell Rep. 2024 Apr 23;43(4):113996. doi: 10.1016/j.celrep.2024.113996. Epub 2024 Mar 24. Cell Rep. 2024. PMID: 38520690 Free PMC article.

7

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.

Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D; CCMR Advisory Board; CCMR-3B STUDY Investigators. Ji L, et al. Among authors: pan c. Am J Med. 2013 Oct;126(10):925.e11-22. doi: 10.1016/j.amjmed.2013.02.035. Epub 2013 Jun 27. Am J Med. 2013. PMID: 23810406

8

Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease.

Lv J, Pan C, Cai Y, Han X, Wang C, Ma J, Pang J, Xu F, Wu S, Kou T, Ren F, Zhu ZJ, Zhang T, Wang J, Chen Y. Lv J, et al. Among authors: pan c. Nat Commun. 2024 Jul 8;15(1):5729. doi: 10.1038/s41467-024-50125-2. Nat Commun. 2024. PMID: 38977723 Free PMC article.

9

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.

Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. Among authors: pan c. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587383 Free PMC article. Clinical Trial.

10

Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity.

Lu X, Zhu X, Li G, Wu L, Shao L, Fan Y, Pan CW, Wu Y, Borné Y, Ke C. Lu X, et al. Among authors: pan cw. J Clin Endocrinol Metab. 2024 Sep 17:dgae552. doi: 10.1210/clinem/dgae552. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39287934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,201 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,201 results

Results by year